摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

tribromo-2-fluoro-ethane

中文名称
——
中文别名
——
英文名称
tribromo-2-fluoro-ethane
英文别名
Tribrom-2-fluor-aethan;HBFC-131B3b;1,1,1-tribromo-2-fluoroethane
tribromo-2-fluoro-ethane化学式
CAS
——
化学式
C2H2Br3F
mdl
——
分子量
284.748
InChiKey
OXNGNBHGFPJLTC-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    2.9
  • 重原子数:
    6
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    1.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    1

反应信息

  • 作为产物:
    描述:
    1,1,2,2-四溴乙烷 在 mercury(II) fluoride 作用下, 生成 tribromo-2-fluoro-ethane
    参考文献:
    名称:
    Iodine Excess and Hyperthyroidism
    摘要:
    150 mug iodine are daily required for thyroid hormone synthesis. The thyroid gland has intrinsic mechanisms that maintain normal thyroid function even in the presence of iodine excess. Large quantities of iodide are present in drugs, antiseptics, contrast media and food preservatives. Iodine induced hyperthyroidism is frequently observed in patients affected by euthyroid iodine deficient goiter when suddenly exposed to excess iodine. Possibly the presence of autonomous thyroid function permits the synthesis and release of excess quantities of thyroid hormones. The presence of thyroid autoimmunity in patients residing in iodine-insufficient areas who develop iodine-induced hyperthyroidism has not been unanimously observed. In iodine-sufficient areas, iodine-induced hyperthyroidism has been reported in euthyroid patients with previous thyroid diseases. Euthyroid patients previously treated with antithyroid drugs for Graves' disease are prone to develop iodine-induced hyperthyroidism. As well, excess iodine in hyperthyroid Graves' disease patients may reduce the effectiveness of the antithyroid drugs. Occasionally iodine-induced hyperthyroidism has been observed in euthyroid patients with a previous episode of post-partum thyroiditis, amiodarone destructive or type II thyrotoxicosis and recombinant interferon-cu induced destructive thyrotoxicosis. Amiodarone administration may induce thyrotoxicosis. Two mechanisms are responsible for this condition. One is related to excess iodine released from the drug, approximately 9 mg of iodine following a daily dose of 300 mg amiodarone. This condition is an iodine-induced thyrotoxicosis or type I amiodarone-induced thyrotoxicosis. The other mechanism is due to the amiodarone molecule that induces a destruction of the thyroid follicles with a release of preformed hormones. This condition is called amiodarone-induced destructive thyrotoxicosis or type II thyrotoxicosis. Patients developing type I thyrotoxicosis in general have preexisting nodular goiter whereas those developing type II thyrotoxicosis have a normal thyroid gland. The latter group of patients, after recovering from the destructive process, may develop permanent hypothyroidism as the consequence of fibrosis of the gland.
    DOI:
    10.1089/105072501300176453
点击查看最新优质反应信息

文献信息

  • Henne, Journal of the American Chemical Society, 1938, vol. 60, p. 1570
    作者:Henne
    DOI:——
    日期:——
  • Swarts, Bulletin de la Societe Chimique de France, 1919, vol. <4>25, p. 168
    作者:Swarts
    DOI:——
    日期:——
  • Sterols. XXIX. Urane Derivatives
    作者:Russell E. Marker、Oliver Kamm、Thomas S. Oakwood、Eugene L. Wittle、Elmer J. Lawson
    DOI:10.1021/ja01272a022
    日期:1938.5
  • Henne; Renoll, Journal of the American Chemical Society, 1936, vol. 58, p. 888
    作者:Henne、Renoll
    DOI:——
    日期:——
  • Swarts, vol. <3>33, p. 441
    作者:Swarts
    DOI:——
    日期:——
查看更多